chr10-97599982-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_138413.4(HOGA1):c.604-85T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.156 in 1,485,160 control chromosomes in the GnomAD database, including 19,382 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.15 ( 1852 hom., cov: 32)
Exomes 𝑓: 0.16 ( 17530 hom. )
Consequence
HOGA1
NM_138413.4 intron
NM_138413.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.26
Publications
16 publications found
Genes affected
HOGA1 (HGNC:25155): (4-hydroxy-2-oxoglutarate aldolase 1) The authors of PMID:20797690 cloned this gene while searching for genes in a region of chromosome 10 linked to primary hyperoxalurea type III. They noted that even though the encoded protein has been described as a mitochondrial dihydrodipicolinate synthase-like enzyme, it shares little homology with E. coli dihydrodipicolinate synthase (Dhdps), particularly in the putative substrate-binding region. Moreover, neither lysine biosynthesis nor sialic acid metabolism, for which Dhdps is responsible, occurs in vertebrate mitochondria. They propose that this gene encodes mitochondrial 4-hydroxyl-2-oxoglutarate aldolase (EC 4.1.3.16), which catalyzes the final step in the metabolic pathway of hydroxyproline, releasing glyoxylate and pyruvate. This gene is predominantly expressed in the liver and kidney, and mutations in this gene are found in patients with primary hyperoxalurea type III. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Nov 2010]
HOGA1 Gene-Disease associations (from GenCC):
- primary hyperoxaluria type 3Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Myriad Women’s Health, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 10-97599982-T-C is Benign according to our data. Variant chr10-97599982-T-C is described in ClinVar as Benign. ClinVar VariationId is 1234774.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.171 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.150 AC: 22854AN: 152038Hom.: 1851 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
22854
AN:
152038
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.156 AC: 208212AN: 1333004Hom.: 17530 Cov.: 21 AF XY: 0.155 AC XY: 103693AN XY: 670016 show subpopulations
GnomAD4 exome
AF:
AC:
208212
AN:
1333004
Hom.:
Cov.:
21
AF XY:
AC XY:
103693
AN XY:
670016
show subpopulations
African (AFR)
AF:
AC:
4574
AN:
30796
American (AMR)
AF:
AC:
2989
AN:
44558
Ashkenazi Jewish (ASJ)
AF:
AC:
3080
AN:
25392
East Asian (EAS)
AF:
AC:
2127
AN:
39132
South Asian (SAS)
AF:
AC:
8947
AN:
83592
European-Finnish (FIN)
AF:
AC:
10026
AN:
53302
Middle Eastern (MID)
AF:
AC:
495
AN:
5508
European-Non Finnish (NFE)
AF:
AC:
167754
AN:
994506
Other (OTH)
AF:
AC:
8220
AN:
56218
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
9415
18830
28245
37660
47075
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
5486
10972
16458
21944
27430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.150 AC: 22862AN: 152156Hom.: 1852 Cov.: 32 AF XY: 0.148 AC XY: 11025AN XY: 74386 show subpopulations
GnomAD4 genome
AF:
AC:
22862
AN:
152156
Hom.:
Cov.:
32
AF XY:
AC XY:
11025
AN XY:
74386
show subpopulations
African (AFR)
AF:
AC:
6112
AN:
41506
American (AMR)
AF:
AC:
1406
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
AC:
432
AN:
3470
East Asian (EAS)
AF:
AC:
279
AN:
5184
South Asian (SAS)
AF:
AC:
499
AN:
4812
European-Finnish (FIN)
AF:
AC:
1959
AN:
10588
Middle Eastern (MID)
AF:
AC:
23
AN:
294
European-Non Finnish (NFE)
AF:
AC:
11818
AN:
68008
Other (OTH)
AF:
AC:
258
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
977
1953
2930
3906
4883
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
264
528
792
1056
1320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
309
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.